PT  - JOURNAL ARTICLE
AU  - Popovych, V.
AU  - Koshel, I.
AU  - Haman, Y.
AU  - Leschak, V.
AU  - Duplikhin, R.
TI  - Diagnostic accuracy and predictive value of clinical symptoms for the diagnosis of mild COVID-19
AID  - 10.1101/2021.03.05.21252963
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.05.21252963
4099  - http://medrxiv.org/content/early/2021/03/08/2021.03.05.21252963.short
4100  - http://medrxiv.org/content/early/2021/03/08/2021.03.05.21252963.full
AB  - Objective To assess the diagnostic accuracy of clinical symptoms and their predictive values in patients with suspected mild COVID-19 and to identify target groups for self-isolation and outpatient treatment without additional testing in the primary health care system.Methods We conducted an open-label prospective study in both male and female patients aged 18 to 72 years with suspected mild COVID-19 who were sequentially enrolled in the study. The clinical diagnosis was performed in accordance with the WHO recommendations based on the acute onset of such symptoms as olfactory dysfunction, hyperthermia, myalgia, nasal congestion, nasal discharge, cough, rhinolalia, sore throat, without pneumonia or hypoxia in persons in contact with a confirmed case of COVID-19. The physician assessed clinical symptoms using a 4-point scale. The patient self-assessed clinical symptoms using a ten-point visual analogue scale (VAS). All enrolled patients underwent laboratory testing to confirm the diagnosis of COVID-19.Results Of the 120 patients underwent testing, the diagnosis of mild COVID-19 was confirmed in 96 patients and ruled out in 24 patients. When assessing symptoms by a physician according to the correlation analysis, hyperthermia, myalgia, nasal congestion and rhinolalia have a positive predictive value with a significance level of more than 0.6. When self-assessing symptoms by a patient, fever, myalgia and nasal congestion have a diagnostic accuracy with a significance level of more than 0.5. Nasal discharge, cough and sore throat have negative predictive values.Discussion The presence of these symptoms in patients with an acute onset of the disease can help to make a clinical diagnosis of coronavirus disease and identify target groups for self-isolation and outpatient treatment without additional testing. Highly suspect asymptomatic patients are not considered as those who have possible mild COVID-19 infection.Registration Ethics Committee of Ivano-Frankivsk National Medical University, Protocol No. 114/20 as of 21 May 2020.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialIn Ukraine there are no requirements for registration of an IIT in the database Clinicaltrial.gov. The investigator is obliged to register it with the ethics committee. The approval number of the ethical commitee for the presented study is №114/20Funding StatementThis work was supported by the research grant from Bionorica SE, Neumarkt, GermanyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approved by IRB (Ethical comittee) of Medical University of Ivano-Frankivsk (lead comission)and by local ethical comittees of all participated sitesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the clinical trial material can be provided by corresponding author upon reasonable request